Smoking Cessation Lever
Quitting smoking is the single highest-yield lever after MI.
- 0–12wk: Relapse window (placeholder metric)
- ~36%: Risk reduction (placeholder estimate)
- Varenicline: Support method (placeholder therapy)
- Weekly: Counseling (placeholder cadence)
Cessation pharmacotherapy and counseling
Combines pharmacologic and behavioral support to prevent relapse.
Exercise Adherence Lever
Supervised aerobic training restores functional capacity over weeks.
- 3: Sessions/wk (placeholder schedule)
- +2–4: METs gain (placeholder range)
- >75%: Adherence target (placeholder goal)
- 12wk: Program length (placeholder duration)
Progressive aerobic conditioning
Intensity ramps gradually under monitored supervision.
Diet Quality Lever
Diet quality shifts inflammatory and metabolic risk markers.
- Mediterranean: Pattern (placeholder diet type)
- <2g/day: Sodium target (placeholder target)
- 30g/day: Fiber goal (placeholder target)
- Monthly: Review (placeholder cadence)
Nutrition counseling protocol
Dietitian-guided adjustments support lipid and glycemic control.
Lipid Control Lever
Statin intensity and adherence drive LDL toward target.
- <70mg/dL: LDL target (placeholder target)
- High-intensity: Statin class (placeholder therapy)
- 6wk: Recheck (placeholder interval)
- Ezetimibe: Add-on (placeholder option)
Lipid-lowering titration
Therapy escalates stepwise until target LDL is reached.
Combined Functional Recovery Trajectory
All four levers blend into one 12-week recovery curve.
- 4: Levers combined (placeholder count)
- 12wk: Horizon (placeholder timeline)
- ~10: Best-case METs (placeholder ceiling)
- Composite: Model type (placeholder label)
Composite recovery modeling
Weighted lever inputs project a single functional recovery curve.
Higher adherence and risk-factor scores compound into faster, higher-plateau recovery.